There are 2789 resources available
LBA14 - Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) + palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2– eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study
Presenter: Sara Hurvitz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
121MO - Acute toxicity associated with a 3-week versus a standard 5-week regimen for locoregional breast radiotherapy delivered in the UNICANCER HypoG-01 phase III trial
Presenter: Sofia Rivera
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
122MO - Quality of life from the Penelope-B study on high-risk HR+/HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib
Presenter: José García-Saenz
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
123MO - BARBICAN: A randomized, phase II study to determine the contribution of ipatasertib to neoadjuvant chemotherapy plus atezolizumab in women with triple-negative breast cancer
Presenter: Peter Schmid
Session: Mini oral session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
515MO - A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC)
Presenter: Joline Lim
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
516MO - Phase I/II study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with solid tumor malignancies
Presenter: Haeseong Park
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Discussion LBA39, LBA40 and 1041MO
Presenter: Teresa Troiani
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Slides
Webcast
Discussion LBA67 and 1743MO
Presenter: Laura Locati
Session: Mini oral session - NETs and endocrine tumours
Resources:
Slides
Webcast
Discussion 1099MO, 1100MO and 1101MO
Presenter: Chris Verslype
Session: Mini oral session - NETs and endocrine tumours
Resources:
Slides
Webcast
Discussion 515MO and 516MO
Presenter: Aung Naing
Session: Mini oral session - Developmental therapeutics
Resources:
Slides
Webcast